Results 31 to 40 of about 101,408 (263)

Table_1_Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer.XLSX

, 2022
BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao (1451017), Junbing Chen (13165587), Xiaozheng Huang (13165593), Yanhua Bai (13165590), Dongfeng Niu (316658), Wei Hou (48073), Mengping Long (8407833), Lixin Zhou (80162), Chen Zhao (225070)   +8 more
core   +1 more source

Urinary cholesterol excretion in men with benign prostatic hyperplasia and carcinoma of the prostate [PDF]

, 1977
Urinary excretion of nonesterified (NEC) and total cholesterol (TC) has been investigated in 79 patients with prostatic adenoma (BPH) and 48 patients with carcinoma of the prostate.
P. GIORDANO, Odom, Lorrie F., Ruiz Jorge, Lissette, Williams, Fiona L. R., Llombart-Bosh, Antonio, Angelika, Pickel, McNeely, Lee K., McCarthy, Donna O., Roy, S., Meagher, David P., Jr., G. MAZZINI, Kumar, Lalit, Bhangui, G. R., Daniel, William E., Lloyd, Owen L., Tandon, P. N., Alegret Rodríguez, Milagros, Pickel, A., Kochupillai, V., Elsässer, Erich, Machado Puerto, Isidro, Karl, Hans Josef, E. TRAVERSI, Dua, Harsch, Stadler, Alexander, Cowpe, Jonathan G., Green, Michael, Jüngst, Dieter, Blake, Marilyn, Marx, Franz J., Poole, Marten A., Haase, Gerald M., Ogden, Graham R.; id_orcid, E. ASCARI, MONTECUCCO, CARLOMAURIZIO, A. RICCARDI   +35 more
core   +1 more source

Association Between Family History of Malignant Neoplasms and Clinicopathological Features of Breast Cancer Patients

Zhongliu Fangzhi Yanjiu, 2020
Objective To investigate the association between family history of malignant neoplasms (MN-FH) and clinicopathological characteristics of patients with breast cancer.
CAO Xinhua, HAN Lifei, LYU Jianxin, HU Haolin, ZHANG Ya'nan   +4 more
doaj   +1 more source

Image_1_Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer.TIF

, 2022
BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao (1451017), Junbing Chen (13165587), Xiaozheng Huang (13165593), Yanhua Bai (13165590), Dongfeng Niu (316658), Wei Hou (48073), Mengping Long (8407833), Lixin Zhou (80162), Chen Zhao (225070)   +8 more
core   +1 more source

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer [PDF]

Journal of Pathology and Translational Medicine, 2015
With the advance in personalized therapeutic strategies in patients with breast cancer, there is an increasing need for biomarker-guided therapy. Although the immunogenicity of breast cancer has not been strongly considered in research or practice, tumor-
Sung Gwe Ahn, Joon Jeong, SoonWon Hong, Woo Hee Jung   +3 more
doaj   +1 more source

Image_2_Comparative proteomic and clinicopathological analysis of breast adenoid cystic carcinoma and basal-like triple-negative breast cancer.TIF

, 2022
BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao (1451017), Junbing Chen (13165587), Xiaozheng Huang (13165593), Yanhua Bai (13165590), Dongfeng Niu (316658), Wei Hou (48073), Mengping Long (8407833), Lixin Zhou (80162), Chen Zhao (225070)   +8 more
core   +1 more source

Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem [PDF]

, 2023
Based on compelling preclinical evidence concerning the progress of our novel ruthenium-based metallotherapeutics, we are focusing research efforts on challenging indications for the treatment of invasive neoplasms such as the triple-negative breast ...
Irace C., Paduano L., Montesarchio D., Piccolo M., Misso G., Bocchetti M., Riccardi C., Trifuoggi M., Santamaria R., Ferraro M. G.   +9 more
core   +2 more sources

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil

Frontiers in Immunology, 2022
Triple-negative breast cancer (TNBC) is known as the most intricate and hard-to-treat subtype of breast cancer. TNBC cells do not express the well-known estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2 ...
Fatemeh Nasiri, Fatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, Maral Mahboubi Kancha, Milad Ahmadi Najafabadi, Faeze Salem, Setareh Dashti Shokoohi, Sahar Evazi Bakhshi, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani   +10 more
doaj   +1 more source

Adenosquamous Variant of Metaplastic Carcinoma of Breast – An Unusual Histological Variant [PDF]

Journal of Clinical and Diagnostic Research, 2015
Metaplastic carcinoma of breast refers to a heterogeneous group of neoplasms characterized by intimate admixture of adenocarcinoma with dominant areas of spindle cell, squamous cell and/ or mesenchymal differentiation.
P.U.Swathy, P.Arunalatha, K.Chandramouleeswari, S.Mary Lily, S.Ramya   +4 more
doaj   +1 more source

Triple-Negative Breast Cancer: Emerging Biomarkers for Early Diagnosis, Prognosis, and Treatment [PDF]

Middle East Journal of Cancer
Breast cancer (BC) is a heterogeneous disease characterized by significant global mortality and incidence rates. Annually, approximately 1 million cases of BC are diagnosed worldwide, with over 170,000 classified as triple-negative.
Zahra Roshanizadeh, Mohammad Reza Haghshenas, Abbas Ghaderi   +2 more
doaj   +1 more source